Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin

Biology of the Neonate

Volumn 77, Issue 3, 2000, Pages 139-146

  Dellagrammaticas, H D ^a   Christodoulou, Ch ^a   Megaloyanni, E ^a   Papadimitriou, M ^a   Kapetanakis, J ^a   Kourakis, G ^a  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

Amikacin; Cephalosporins; Meningitis; Neonate

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL;

ARTICLE; BACTERIAL MENINGITIS; BRAIN ABSCESS; BRAIN VENTRICULITIS; CEREBROSPINAL FLUID SHUNTING; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; RELAPSE; RETROSPECTIVE STUDY; SURVIVAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MIRABILIS; NEGIBACTERIA; PROTEUS MIRABILIS;

EID: 0034021137     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014208     Document Type: Article

References (49)

1. Klein JO, Marcy SM: Bacterial sepsis and meningitis: in Remington JS, Klein JO (eds): Infectious Diseases of the Fetus and the Newborn, ed 4. Philadelphia, Saunders, 1997, pp 835-890.
2. Placzek MM, Whitelaw A: Early and late neonatal septicaemia. Arch Dis Child 1983;58: 728-731.
3. Moreno-Vargas S, Poveda R, Saez-Llorens X: Neonatal sepsis and meningitis in a developing Latin American country. Pediatr Infect Dis J 1994;13:516-520.
4. Rennie JM: Bacterial and fungal infections: in Levene MI, Lilford RJ (eds): Fetal and Neonatal Neurology and Neurosurgery, ed 2. New York, Churchill Livingstone, 1995, pp 473-499.
5. Unhanand M, Mustafa M, McCracken GH, Nelson JD: Gram-negative enteric bacillary meningitis. A twenty-one year experience. J Pediatr 1993;122:15-21.
6. Franco SM, Cornelius VE, Andrews BF: Longterm outcome of neonatal meningitis. Am J Dis Child 1992;146:567-571.
7. Anderson SG, Gilbert GL: Neonatal gram-negative meningitis. A 10-year review with reference to outcome and relapse of infection. J Pediatr Child Health 1990;26:212-216.
8. Bell AH, Brown D, Halliday HL, McClure G, McReid M: Meningitis in the newborn - a 14 year review. Arch Dis Child 1989;64:873-874.
9. Volpe JJ: Bacterial and fungal intracranial infections; in Volpe JJ (ed): Neurology of the Newborn, ed 3. Philadelphia. Saunders. 1995, pp 730-766.
10. Elliot TS, Ispahani P, Cowlishaw WA: Gram-negative bacillary meningitis in neonates. A glimmer of therapeutic success. J Antimicrob Chemother 1986;17:245-250.
11. Kaplan SL, Patrick CP: Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms. Pediatr Infect Dis J 1990;9:810-814.
12. Feldstein IJ, Uden DL, Larson JA: Cefotaxime for treatment of gram-negative meningitis in infants and children. Pediatr Infect Dis J 1987; 6:471-475.
13. Odio CM: Cefotaxime for treatment of neonatal sepsis and meningitis. Diagn Microbiol Infect Dis 1995;22:111-117.
14. Klein JO, Feigin RD, McCracken GH Jr: Report of the task force on diagnosis and management of meningitis. Pediatrics 1986;78(suppl): 959-982.
15. Klass PE, Klein JO: Therapy of bacterial sepsis and otitis media in infants and children: 1992 poll of directors of programs in pediatric infectious diseases. Pediatr Infect Dis J 1992;11: 702-705.
16. Belohradsky BH, Geiss D, Marget W, Bruck K, Kafetzis D, Peters G: Intravenous cefotaxime in children with bacterial meningitis. Lancet 1980;1:61-63.
17. Kafetzis DA, Brater DC, Kapiki AN, Papas CV, Dellagrammaticas H, Papadatos CJ: Treatment of severe infections with cefotaxime: Efficacy and pharmacokinetics. J Pediatr 1982;100:483-489.
18. Naqvi SH, Maxwell MA, Junkle LM: Cefotaxime therapy of neonatal gram-negative bacillary meningitis. Pediatr Infect Dis J 1985;4:449-502.
19. Heldstein IJ, Uden DL, Larson TA: Cefotaxime for treatment of gram-negative bacterial meningitis in infants and children. Pediatr Infect Dis J 1987;6:471-475.
20. Lecour H, Seara A, Miranda AM, Cordeiro J, Sermento J: Treatment of 160 cases of acute bacterial meningitis with cefotaxime. J Antimicrob Chemother 1984;14(suppl B):195-202.
21. Gandy G, Rennie J: Antibiotic treatment for suspected neonatal meningitis. Arch Dis Child 1990;65:1-2.
22. Isaacs D, Moxon ER: Meningitis; in Isaacs D, Moxon ER (eds): Neonatal Infections, Oxford, Butterworth-Heinemann, 1991, pp 57-69.
23. Sarman G, Moise AA, Edwards MS: Meningeal inflammation in neonatal gram-negative bacteremia. Pediatr Infect Dis J 1995;14:701-704.
24. Chamberlain J, Coombs JD, Dell D, Fromson JM, Ings RJ, Macdonald CM, McEwen J: Metabolism of cefotaxime in animal and man. J Antimicrob Chemother 1980;6(suppl A):69-78.
25. Jones RN, Barry AL, Thornsberry C: Antimicrobial activity of desacetyl cefotaxime alone and in combination with cefotaxime: Evidence of synergy. Rev Infect Dis 1982;4:S366-373.
26. Jones RN, Barry AL: Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime and cefotaxime-desacetylcefotaxime in the presence of human serum. Antimicrob Agents Chemother 1987;31:818-820.
27. Wells TG, Tsang JM, Brown AL, Marmer BC, Jacobs RF: Cefotaxime therapy of bacterial meningitis in children. J Antimicrob Chemother 1984;14(suppl B):181-189.
28. Glew RH, Pavuk RA: Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae. Antimicrob Agents Chemother 1984;26:378-381.
29. Jones RN, Packer RR: Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third generation cephalosporins. Antimicrob Agents Chemother 1982;22:985-999.
30. Francis BM, Gilbert GL: Survey of neonatal meningitis in Australia: 1987-1989. Med J Aust 1992;156:240-243.
31. Tessin I, Trollfors B, Thiringer K, Larsson P: Ampicillin-aminoglycoside combinations as initial treatment for neonatal septicaemia or meningitis. Acta Paediatr Scand 1991;80:911-916.
32. Sarff LD, Platt LH, McCracken GH: Cerebrospinal fluid evaluation in neonates. Comparison of high-risk infants with and without meningitis. J Pediatr 1976;88:473-477.
33. Rodriguez AF, Kaplan SL, Mason EO: Cerebrospinal fluid values in the very low birth weight infant. J Pediatr 1990;116:971-974.
34. Rubinstein JS, Yogef R: What represents pleocytosis in blood contaminated ('traumatic tap') cerebrospinal fluid in children? J Pediatr 1985; 107:249-252.
35. Novak RW: Lack of validity of standard corrections for white blood cell counts of blood-contaminated cerebrospinal fluid in infants. Am J Clin Pathol 1984;82:95-97.
36. Mathers NJ, Polhandt F: Diagnostic audit of C-reactive protein. Eur J Pediatr 1987;146: 147-151.
37. Poletola HO: C-reactive protein for rapid monitoring of infections of the central nervous system. Lancet 1982;i:980-982.
38. Peltola HO, Luhtala K, Valmari P: C-reactive protein as a detector of organic complications during recovery from childhood purulent meningitis. J Pediatr 1984;104:869-872.
39. Philip AGS, Baker CJ: Cerebrospinal fluid C-reactive protein in neonatal meningitis. J Pediatr 1983;102:715-717.
40. McCracken GH, Mustafa MM, Ramilo O, Olsen KD, Risser RC: Cerebrospinal fluid interleukin-1 beta and tumour necrosis factor concentrations and outcome from neonatal Gram-negative enteric bacillary meningitis. Pediatr J Infect Dis 1989;8:155-159.
41. Roberton NRC: Infection in the newborn: in Roberton NRC (ed): Textbook of Neonatology, ed 2. New York, Churchill Livingstone, 1992, pp 943-1005.
42. Schaad UB, Nelson JD, McCracken GH: Recrudescence and relapse in bacterial meningitis in childhood. Pediatrics 1981;67:188-195.
43. McCracken GH: The rate of bacteriologic response to antimicrobial therapy in neonatal meningitis. Am J Dis Child 1972;123:547-553.
44. Glode MP, Sutton A, Moxon ER, Robbins JB: Pathogenesis of neonatal Escherichia coli meningitis: Induction of bacteremia and meningitis in infant rats fed E. coli K1. Infect Immun 1977;16:75-80.
45. McCracken GH, Sarff LD, Glode MP, Mize SG: Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet 1974;2: 246-250.
46. Mulder CJ, van Alpen L, Zanen HC: Neonatal meningitis caused by Escherichia coli in the Netherlands. J Infect Dis 1984;150:935-940.
47. Bell WE, McGuiness GA: Suppurative central nervous system infections in the neonate. Semin Perinatol 1982;6:1-24.
48. Mustafa MM, Mertsola J, Ramilo O, Saez-Llorens X, Risser RC, McCracken GH Jr: Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. J Infect Dis 1989;160:891-895.
49. Plotkin SA, Halsey NA, Lepow ML, Committee on Infectious Diseases: Dexamethasone therapy for bacterial meningitis in infants and children. Pediatrics 1990;86:130-133.